van Houdt Winan J, Fiore Marco, Barretta Francesco, Rutkowski Piotr, Blay Jean-Yves, Lahat Guy, Strauss Dirk, Gonzalez Ricardo J, Ahuja Nita, Grignani Giovanni, Quagliuolo Vittorio, Stoeckle Eberhard, De Paoli Antonino, Schrage Yvonne, Cardona Kenneth, Pennacchioli Elisabetta, Pillarisetty Venu G, Nessim Carolyn, Swallow Carol J, Bagaria Sanjay P, Canter Robert, Mullen John T, Callegaro Dario, Fairweather Mark, Miceli Rosalba, Raut Chandrajit P, Gronchi Alessandro, Gladdy Rebecca A
Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cancer. 2020 Nov 15;126(22):4917-4925. doi: 10.1002/cncr.33139. Epub 2020 Aug 14.
In this series from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), the authors examined longitudinal outcomes of patients with a second recurrence of retroperitoneal sarcoma (RPS) after complete resection of a first local recurrence (LR).
Data from patients undergoing resection of a first LR from January 2002 to December 2011were collected from 22 sarcoma centers. The primary outcome was overall survival (OS) after second recurrence.
Second recurrences occurred in 400 of 567 patients (70.5%) after an R0/R1 resection of a first locally recurrent RPS. Patterns of disease recurrence were LR in 323 patients (80.75%), distant metastases (DM) in 55 patients (13.75%), and both LR and DM in 22 patients (5.5%). The main subtype among the LR group was liposarcoma (77%), whereas DM mainly were leiomyosarcomas (43.6%). In patients with a second LR only, a total of 200 patients underwent re-resection (61.9%). The 5-year OS rate varied significantly based on the pattern of failure (P < .001): 45.6% for the LR group, 25.5% for the DM group, and 0% for the group with LR and DM. The only factors found to be associated with improved OS on multivariable analysis were both time between second surgery and the development of the second recurrence (32 months vs 8 months: hazard ratio, 0.44 [P < .001]) and surgery for second recurrence (yes vs no: hazard ratio, 3.25 [P < .001]). The 5-year OS rate for patients undergoing surgery for a second LR was 59% versus 18% in the patients not deemed suitable for surgical resection.
Survival rates after second recurrence of RPS varied based on patterns of disease recurrence and treatment. Durable disease-free survivors were identified after surgery for second LR in patients selected for this intervention.
在来自跨大西洋澳大拉西亚腹膜后肉瘤工作组(TARPSWG)的本系列研究中,作者检查了首次局部复发(LR)完全切除后腹膜后肉瘤(RPS)第二次复发患者的纵向结局。
收集了2002年1月至2011年12月期间在22个肉瘤中心接受首次LR切除的患者的数据。主要结局是第二次复发后的总生存期(OS)。
567例患者中有400例(70.5%)在首次局部复发的RPS进行R0/R1切除后出现第二次复发。疾病复发模式为323例患者(80.75%)出现LR,55例患者(13.75%)出现远处转移(DM),22例患者(5.5%)同时出现LR和DM。LR组的主要亚型是脂肪肉瘤(77%),而DM主要是平滑肌肉瘤(43.6%)。仅在第二次出现LR的患者中,共有200例患者接受了再次切除(61.9%)。5年OS率根据失败模式有显著差异(P <.001):LR组为45.6%,DM组为25.5%,同时出现LR和DM的组为0%。多变量分析中发现与OS改善相关的唯一因素是第二次手术与第二次复发发生之间的时间(32个月对8个月:风险比,0.44 [P <.001])以及第二次复发的手术(是与否:风险比,3.25 [P <.001])。接受第二次LR手术的患者5年OS率为59%,而不适合手术切除的患者为18%。
RPS第二次复发后的生存率因疾病复发模式和治疗而异。在选择进行该干预的患者中,第二次LR手术后确定了持久的无病生存者。